Back

Real-life adverse events with SGLT-2 inhibitors: different safety profiles according to their indications?

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Pharmacology and pharmacotherapy Antidiabetic Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Omar Chebbo

Montpellier (France)

5 More presentations in this session

Presentation thumbnail
Empaglifozin modifies the arterial stiffness in type-2 diabetic patients: a preliminary report
Doctor M. Feola (Mondovi, IT)
Abstract Slides
Presentation thumbnail
Assessing doctors' knowledge and confidence regarding SGLT2 inhibitor prescribing practices, side-effects, and ESC guidelines
Doctor E. Higgisson (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
Efficacy of ARNI in patients using LVAD: a systematic review and meta-analysis
Doctor E. Hasabo (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Intravenous iron therapy for patients with heart failure and iron deficiency: an updated meta-analysis of randomized controlled trials
Mr G. Yeap (GB)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of SGLT2-i in patients using LVAD: a systematic review and meta-analysis
Doctor E. Hasabo (Galway, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacology and pharmacotherapy

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Real-life data on the tolerability of SGLT2 inhibitors in elderly patients with heart failure
thumbnail
Congress Presentation
A real-world population with HFrEF treated with dapagliflozin or empagliflozin: a comparative analysis with DAPA-HF and EMPEROR REDUCED studies
thumbnail
Congress Presentation
Impact of SLGT2 inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac defibrillator

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources